Cost of care for new-onset acute coronary syndrome patients who undergo coronary revascularization

Journal of Invasive Cardiology

Volumn 17, Issue 6, 2005, Pages 307-311

  McCollam, Patrick ^a   Etemad, Lida ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; STATIN; DRUG DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TICLOPIDINE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DEMOGRAPHY; EMERGENCY WARD; FEMALE; FOLLOW UP; HEALTH CARE UTILIZATION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HOSPITAL COST; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; UNSTABLE ANGINA PECTORIS; ACUTE DISEASE; ADOLESCENT; ECONOMICS; HEALTH CARE COST; HEALTH INSURANCE; HEALTH SERVICE; HEART INFARCTION; METHODOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; TIME; UNITED STATES; UTILIZATION REVIEW;

ACUTE DISEASE; ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; ANGINA, UNSTABLE; FEMALE; HEALTH CARE COSTS; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MANAGED CARE PROGRAMS; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PROSPECTIVE STUDIES; TICLOPIDINE; TIME FACTORS; UNITED STATES;

EID: 26044469157     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Kong DF, Blazing MA, O'Connor CM, et al. The health care burden of unstable angina. Cardiology Clinics 1999;17:247-261.
2. Eisenstein EL, Shaw LK, Anstrom KJ, et al. Assessing the clinical and economic burden of coronary artery disease: 1986-1998. Medical Care 2001;39:824-835.
3. Russell MW, Huse DM, Drowns S, et al. Direct medical costs of coronary artery disease in the United States. Am J Cardiol 1998;81:1110-1115.
4. Bloom BS, Tibi-Lévy Y, Harari A, Fendrick AM. Direct medical care costs of unstable angina pectoris in a defined population. J Man Care Pharm 1999;5:39-44.
5. Etemad LR, McCollam P. Total cost of acute coronary syndromes patients in a managed care population during the one-year following initial presentation. J Man Care Pharm 2004;10:202.
6. Wallentin L, Lagerqvist B, Husted S, et al. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary artery disease: The FRISC II invasive randomized trial. Lancet 2000;356:9-16.
7. Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001;344:1879-1887.
8. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: Summary article: A report of the American College Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 2002;40:1366-1374.
9. Anderson HV, Shaw RE, Brindis RG, et al. A contemporary overview of percutaneous coronary interventions The American College of Cardiology - National Cardiovascular Data Registry (ACC-NCDR). J Am Coll Cardiol 2002;39:1096-1103.
10. Eagle KA, Guyton RA, Davidoff R, et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). American College of Cardiology Web Site. http://www.acc.org/clinical/ guidelines/cabg/cabg.pdf accessed 12/1/2004.
11. Levine GN, Kern MJ, Berger PB, et al. for the American Heart Association Diagnostic and Interventional Catheterization Committee and Council on Clinical Cardiology. Management of patients undergoing percutaneous coronary revascularization. Ann Intern Med 2003;139:123-136.
12. Stafford RS, Radley DC. The underutilization of cardiac medications of proven benefit, 1990 to 2002. J Am Coll Cardiol 2003;41:56-61.
13. Miller RR, Li Y-F, Sun H, et al. Underuse of cardioprotective medications in patients prior to acute myocardial infarction. Am J Cardiol 2003;92:209-211.
14. Bhatt DL, Roe MT, Peterson ED, et al. Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE quality improvement initiative. JAMA 2004;292:2096-2104.
15. Grech ED, Ramsdale DR. ABC of interventional cardiology. Acute coronary syndrome: unstable angina and non-ST segment elevation myocardial infarction. Br Med J 2003;326:1259-1261.
16. Schneeweiss R, Cherkin DC, Hart LG, et al. Diagnosis clusters adapted for ICD-9-CM and CDHPPC-2. J Fam Pract 1986;22:69-72.
17. Kozak LJ, Hall MJ, Owings MF. National Hospital Discharge Survey: 2000 annual summary with detailed diagnosis and procedure data. National Center for Health Statistics. Vital Health Stat 2002;153:1-194.
18. Hlatky MA, Rogers WJ, Johnstone I, et al. Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. N Engl J Med 1997;336:92-99.
19. Hlatky MA, Boothroyd D, Brooks MM, et al. Clinical correlates of the initial and long-term cost of coronary bypass surgery and coronary angioplasty. Am Heart J 1999;138:376-383.
20. Steinhubl SR, Berger PB, Mann JT, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention. JAMA 2002;288:2411-2420.